Thomsen H S, Bush W H
Department of Diagnostic Radiology, Copenhagen University Hospital at Herlev, Denmark.
Drug Saf. 1998 Oct;19(4):313-24. doi: 10.2165/00002018-199819040-00006.
Although contrast media are relatively well tolerated, a non-life-threatening, moderate reaction requiring some treatment occurs in 1 to 2% of patients receiving ionic high-osmolar contrast media and in 0.2 to 0.4% of patients receiving non-ionic low-osmolar contrast media. Severe, life-threatening reactions can be expected in about 0.2% of patients after injection of ionic high-osmolar and 0.04% after non-ionic low-osmolar contrast media. Prompt recognition and treatment are invaluable in blunting an adverse response of a patient to radiographic contrast material, and may prevent a reaction from becoming severe or even life-threatening. Some reactions can be prevented by pretreatment before administration of contrast media. Knowledge, training and preparation are crucial in guaranteeing appropriate and effective therapy in the event of an adverse contrast-related event. Radiologists and their staff should review treatment protocols regularly so that each can accomplish his or her role efficiently.
尽管造影剂的耐受性相对良好,但在接受离子型高渗造影剂的患者中,有1%至2%会出现需要某种治疗的非危及生命的中度反应,而在接受非离子型低渗造影剂的患者中,这一比例为0.2%至0.4%。注射离子型高渗造影剂后,预计约0.2%的患者会出现严重的、危及生命的反应,注射非离子型低渗造影剂后这一比例为0.04%。迅速识别和治疗对于减轻患者对放射造影剂的不良反应非常重要,并且可能防止反应变得严重甚至危及生命。在给予造影剂之前进行预处理可以预防一些反应。在发生与造影剂相关的不良事件时,知识、培训和准备对于确保适当和有效的治疗至关重要。放射科医生及其工作人员应定期审查治疗方案,以便每个人都能有效地履行自己的职责。